Nipple Paget’s illness was originally identified in 1874. It is a malignant condition that causes the disappearance of the nipple and eczematous changes over the nipple and areolar and is frequently linked to underlying cancer in situ. ¹ In the epidermal layer, typical large clear cells (Paget’s cells) can be seen under a microscope. These cells have pleomorphic and hyperchromatic nuclei, prominent nucleoli, and an abundance of pale cytoplasm. Paget’s breast disease is most common in postmenopausal women with age group of >50 years. ^{2 , 3} The most frequent association with Paget’s disease of the breast is ulceration and destruction of the nipple and areola. Ultrasonography and mammography of the breast help identify the underlying cause. Biopsy is done for a confirmatory diagnosis. Our case is Paget’s disease without any lump underneath.

We report the case of a 71-year-old woman. She is a house-wife and is Caucasian with no past medical or family history who reported to the outpatient clinic with chief complaints of itching, wound, and destruction of the right nipple and areola of the breast for three years. She also had complaints of breathlessness, weakness, and decreased appetite. The examination revealed ulceration, destruction of the nipple-areolar complex, irregular margins, uneven surface, blackening of surrounding skin, and right axillary lymphadenopathy present ( Figures 1 and 2). The results of routine blood investigations suggestive of raised WBC (white blood cells) counts, 21,900 per microliter (normal range: 4,500 to 11,000 WBCs per microliter). There was no palpable breast mass. The left breast and axilla were normal, with no evidence of any lump. Ultrasonography and mammography did not reveal any lump. A respiratory examination revealed decreased right-sided breath sounds. The patient had not undergone any intervention in the past.

Nipple Paget’s illness was originally identified in 1874. It is most common in the age group between 50 to 70 years. Paget’s disease is a malignant disease. The nipple-areolar complex initially develops eczematous alterations due to the disease, and in later stages, the nipple-areolar complex will be destroyed by ulceration. ⁴ Paget’s nipple illness may be connected to primary invasive or in situ breast cancer. ⁵ As the condition progresses, it first manifests as eczematous alterations of the nipple-areolar complex, changes in skin tone, ulceration, burning sensations, and bleeding of the nipple. It might or might not be connected to a bulge underneath. Only 2% to 3% of all cases of breast cancer are caused by the condition. The migration of ductal carcinoma from which Paget’s cells originated is the most widely accepted explanation. ¹

What is extremely unusual about this case is the malignancy had spread to the adjacent structures and led to malignant pleural effusion.

The generally recognized migratory idea states that ductal carcinoma in situ cells migrate from the primary tumor to the nipple and surrounding skin via milk ducts. The initial presentation of Paget’s disease of the breast is an eczematous lesion, similar to contact dermatitis, in the skin of the breast at the areola and/or nipple and is refractory to usual topical treatments. ⁶

The underlying duct carcinoma cells share similarities with Paget cells in terms of HER2 oncogene positive and epithelial cell characteristics. The precise mechanisms are less clear, although interactions between the HER2 on the tumor cells and the heregulin-alpha protein produced by nipple epidermal keratinocytes have been linked to the chemotaxis. ⁷

If conservative breast surgery is intended, it is imperative to confirm preoperatively through clinical, radiological, and histological investigation that the patient is tumor-free. ^{8 – 10}

The biopsy is crucial for making a Paget’s disease diagnosis. Clinical breast examination is more significant than a biopsy. A clinical breast exam can detect an associated breast lump in about 50% of people with Paget’s disease. When a breast lump can be felt, a mammography, magnetic resonance imaging (MRI) scan, or ultrasound examination is required. In Paget’s disease, CD138 and p53 are regarded as positive and detrimental in the typically present Toker cells. ²

Chemotherapy – for people with invasive ductal carcinoma, chemotherapy may be given before surgery to shrink the tumor or after surgery to reduce the chance of cancer returning. Chemotherapy may also be recommended as the main treatment for people with metastatic breast cancer. ¹¹

Radiation – in most breast cancer cases, radiation therapy is used after surgery to kill any remaining cancer cells. Occasionally, it may be used to shrink a tumor before surgery. Radiation therapy may also be recommended when a tumor can’t be surgically removed due to the size or location. ¹²

Mastectomy with or without the removal of axillary lymph nodes on the same side was considered the standard surgery for Paget’s breast disease. Most of the patients suffer along with the underlying tumor. So removing only the nipple and areola doesn’t cure the disease. Recent studies have demonstrated that radiation therapy followed by conservative breast surgery is an effective choice for individuals with limited disease. Long-term breast-conserving surgery would be comparable to mastectomy in terms of overall survival without disease. ¹³

Patients with Paget’s breast disease and a breast tumor should undergo a mastectomy along with a sentinel lymph node biopsy to check for axillary lymph node dissemination. If the sentinel node is positive, axillary clearing is performed. ¹⁴

Early detection is necessary for Paget’s illness of the breast. About 1%–3% of primary breast cancer cases are caused by Paget’s breast disease. Breast cancer is sporadic in nature. The biopsy is a must for diagnosis of disease in patients with normal ultrasound and mammogram. Disease management depends on the underlying tumor, the spread of the disease, and the presence or absence of an underlying lump. The presence of a palpable tumor, the extent of primary cancer, and the presence of distant metastases all affect the prognosis.

Written informed consent for publication of their clinical details and clinical images was obtained from the patient.